List of Tables
Summary Table: Global Market for Pharmaceutical Excipients, by Material Type, Through 2029
Table 1: Cases of Diabetes, by Country, 2021
Table 2: People Living with HIV Globally, by Region, 2022
Table 3: Global Incidence of All Cancers, by Region, 2022-2045
Table 4: Clinical Trials of Pharmaceutical Excipients
Table 5: Global Market for Pharmaceutical Excipients, by Material Type, Through 2029
Table 6: Global Market for Organic Excipients, by Product Type, Through 2029
Table 7: Global Market for Carbohydrate Pharmaceutical Excipients, by Type, Through 2029
Table 8: Global Market for Sugar Pharmaceutical Excipients, by Type, Through 2029
Table 9: Global Market for Cellulose Pharmaceutical Excipients, by Type, Through 2029
Table 10: Global Market for Starch Pharmaceutical Excipients, Through 2029
Table 11: Global Market for Petrochemical-based Pharmaceutical Excipients, by Type, Through 2029
Table 12: Global Market for Mineral Hydrocarbon-based Pharmaceutical Excipients, by Type, Through 2029
Table 13: Global Market for Oleochemical-based Pharmaceutical Excipients, by Type, Through 2029
Table 14: Global Market for Protein-based Pharmaceutical Excipients, by Type, Through 2029
Table 15: Global Market for Other Organic Pharmaceutical Excipients, by Type, Through 2029
Table 16: Global Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 17: Global Market for USP Water, Through 2029
Table 18: Global Market for Pharmaceutical Excipients, by Dosage Form, Through 2029
Table 19: Global Market for Pharmaceutical Excipients, by Route of Administration, Through 2029
Table 20: Global Market for Pharmaceutical Excipients, by End User, Through 2029
Table 21: Global Market for Pharmaceutical Excipients, by Region, Through 2029
Table 22: North American Market for Pharmaceutical Excipients, by Country, Through 2029
Table 23: European Market for Pharmaceutical Excipients, by Country, Through 2029
Table 24: Asia-Pacific Market for Pharmaceutical Excipients, by Country, Through 2029
Table 25: Latin American Market for Pharmaceutical Excipients, by Country, Through 2029
Table 26: RoW Market for Pharmaceutical Excipients, Through 2029
Table 27: North American Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 28: U.S. Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 29: Canadian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 30: Mexican Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 31: European Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 32: German Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 33: French Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 34: U.K. Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 35: Italian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 36: Spanish Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 37: Rest of European Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 38: Asia-Pacific Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 39: Chinese Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 40: Japanese Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 41: Indian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 42: Rest of Asia-Pacific Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 43: Latin American Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 44: Brazilian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 45: Argentinian Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 46: Chilean Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 47: RoW Market for Organic Pharmaceutical Excipients, by Type, Through 2029
Table 48: North American Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 49: U.S. Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 50: Canadian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 51: Mexican Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 52: European Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 53: German Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 54: French Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 55: U.K. Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 56: Italian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 57: Spanish Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 58: Rest of European Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 59: Asia-Pacific Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 60: Chinese Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 61: Japanese Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 62: Indian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 63: Rest of Asia-Pacific Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 64: Latin American Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 65: Brazilian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 66: Argentinian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 67: Chilean Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 68: RoW Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029
Table 69: ESG: Environmental Performance
Table 70: ESG: Social Performance
Table 71: ESG: Governance Performance
Table 72: Abbreviations Used in This Report
Table 73: ADM: Company Snapshot
Table 74: ADM: Financial Performance, 2022 and 2023
Table 75: ADM: Product Portfolio
Table 76: Asahi Kasei Corp.: Company Snapshot
Table 77: Asahi Kasei Corp.: Financial Performance, 2022 and 2023
Table 78: Asahi Kasei Corp.: Product Portfolio
Table 79: Ashland: Company Snapshot
Table 80: Ashland: Financial Performance, 2022 and 2023
Table 81: Ashland: Product Portfolio
Table 82: Ashland.: News/Key Developments, 2022
Table 83: BASF SE: Company Snapshot
Table 84: BASF SE: Financial Performance, 2022 and 2023
Table 85: BASF SE: Product Portfolio
Table 86: BASF SE: News/Key Developments, 2023
Table 87: Croda International Plc: Company Snapshot
Table 88: Croda International Plc: Financial Performance, 2022 and 2023
Table 89: Croda International Plc: Product Portfolio
Table 90: Croda International Plc: News/Key Developments, 2023
Table 91: Evonik Industries AG: Company Snapshot
Table 92: Evonik Industries AG: Financial Performance, 2022 and 2023
Table 93: Evonik Industries AG: Product Portfolio
Table 94: Evonik.: News/Key Developments, 2023
Table 95: Ingredion: Company Snapshot
Table 96: Ingredion: Financial Performance, FY 2022 and 2023
Table 97: Ingredion: Product Portfolio
Table 98: Ingredion: News/Key Developments, 2023
Table 99: Kerry Group Plc: Company Snapshot
Table 100: Kerry Group Plc: Financial Performance, 2022 and 2023
Table 101: Kerry Group Plc: Product Portfolio
Table 102: Kerry Group Plc: News/Key Developments, 2023
Table 103: Roquette Frères: Company Snapshot
Table 104: Roquette Frères: Product Portfolio
Table 105: Roquette Frères: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure A: Global Market for Pharmaceutical Excipients, by Material Type, 2021-2029
Summary Figure B: Global Market Shares of Pharmaceutical Excipients, by Material Type, 2023
Figure 1: Pharmaceutical Excipients: Market Dynamics
Figure 2: Emerging Trends and Technologies in Pharmaceutical Excipients
Figure 3: Global Market Shares of Pharmaceutical Excipients, by Company, 2023
Figure 4: ESG Pillars
Figure 5: Advantages of ESG for Pharmaceutical Excipient Companies
Figure 6: ADM: Revenue Share, by Business Unit, 2023
Figure 7: Asahi Kasei Corp.: Revenue Share, by Business Unit, 2023
Figure 8: Asahi Kasei Corp.: Revenue Share, by Country/Region, 2023
Figure 9: Ashland: Revenue Share, by Business Unit, 2023
Figure 10: Ashland: Revenue Share, by Region, 2023
Figure 11: BASF SE: Revenue Share, by Business Unit, 2023
Figure 12: BASF SE: Revenue Share, by Region, 2023
Figure 13: Croda International Plc: Revenue Share, by Business Unit, 2023
Figure 14: Croda International Plc: Revenue Share, by Region, 2023
Figure 15: Evonik Industries AG: Revenue Share, by Business Unit, 2023
Figure 16: Evonik Industries AG: Revenue Share, by Region, 2023
Figure 17: Ingredion: Revenue Shares, by Business Unit, 2023
Figure 18: Ingredion: Revenue Share, by Region, 2023
Figure 19: Kerry Group Plc: Revenue Share, by Business Unit, 2023
Figure 20: Kerry Group Plc: Revenue Share, by Region, 2023